机构:[1]Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]Department of Oncology, Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.[3]School of Computer Science and Engineering, Shenzhen Institute for Advanced Study, University of Electronic Science and Technology of China, Chengdu, China.
The National Key Research and
Development Program of China, Grant/
Award Number: 2021YFE0206600;
National Natural Science Foundation
of China, Grant/Award Number:
82172842&81672386; Sichuan Science
and Technology Program, Grant/
Award Number: 2022YFSY0012,
2021ZYCD011, 2021YFSY0008,
2021CDDZ-25
and 2021CDZG-24;
Chengdu International Science and
Technology Cooperation Program,
Grant/Award Number: 2022-GH03-
00004-
HZ;
West China Nursing
Discipline Development Special
Fund Project, Grant/Award Number:
HXHL21008; Translational medicine
fund of West China Hospital,Grant/Award Number: CGZH19002;
the Post-Doctor
Research Project, West
China Hospital, Sichuan University,
Grant/Award Number: 2020HXBH119;
the China Medical Board and clinical
research incubation project of West
China Hospital, Grant/Award Number:
Grant#22-482&
20HXFH037; the
Science and technology project of the
Health planning committee of Sichuan
and Chengdu, Grant/Award Number:
2020035&2021115; Xinglin Scholars
Program of Chengdu University of
Traditional Chinese Medicine, Grant/
Award Number: YYZX2021039;
Chengdu Fifth People’s Hospital
Scientific Research Project, Grant/
Award Number: KYJJ2021-05;
Chengdu
Fifth People's Hospital Teaching
Reform Research Project, Grant/Award
Number: JGZX202214
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|3 区肿瘤学
最新[2023]版:
大类|2 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.[2]Department of Oncology, Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.[3]School of Computer Science and Engineering, Shenzhen Institute for Advanced Study, University of Electronic Science and Technology of China, Chengdu, China.[*1]Department of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.[*2]School of Computer Science and Engineering, Shenzhen Institute for Advanced Study, University of Electronic Science and Technology of China, Chengdu 611731, China.
推荐引用方式(GB/T 7714):
Zhang Weiwei,Ling Yawen,Li Zhidong,et al.Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer[J].Cancer medicine.2023,doi:10.1002/cam4.5590.
APA:
Zhang Weiwei,Ling Yawen,Li Zhidong,Peng Xingchen&Ren Yazhou.(2023).Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer.Cancer medicine,,
MLA:
Zhang Weiwei,et al."Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer".Cancer medicine .(2023)